Target SP $1.20 in three months, page-2

I suggest a little caution stock2016

1. Shine are not benefitting from Slater and Gordon, SGH business in Australia is tracking to expectation (except the minor GL business but that is being addressed). It is profitable at operation level.

2. Contrary to what a poster said on this forum a few days ago - Slater and Gordon are accepting clientele as per normal pre-acceptance meritorious claim criteria. The bank syndicate are not insisting no more investment with an intention to recover their loans by extracting WIP - this was incorrect information.

3. Contrary to previous comments, Slater and Girdon are not losing staff, turnover in Australia is not out of the ordinary - in the UK turnover is above normal but that is to be expected in the midst of a restructure and in fact assists the process by achieving the desired staff base numbers through natural attrition.

Best wishes to Shine and its investors. I like the sector and there is room for both Shine and Slater. However, Slater have moved on to a different level and through diversity and scale it is a different proposition to Shine. Those not fully aware will have missed that half of H1FY16 Slater SGS revenues did not originate from legal and was profitable with a 12% return. Whatsmore the SGS loss is more than accounted for in an investment that will return cash this half and through FY2017 purely a timing issue.

I can see Shine make a steady recovery into $1 plus within this calendar year. Slater has potential for returns of a far greater magnitude both short and long term.

Good luck but focus on Shine, do not hope or expect any windfall from Slater and Gordon's business.

Hope this helps.